Emmaus Life Sciences grants North American license for Endari to NeoImmuneTech Dec 30, 2025 04:30PM
Emmaus Life Sciences, Inc. (EMMA) Reports Q2 Loss of $0.02 Aug 14, 2025 04:44PM
Emmaus Life Sciences (EMMA) receives FDA approval for Endari Jun 26, 2025 09:30AM
Emmaus Life Sciences, Inc. (EMMA) Reports Q1 Loss of $0.04 May 16, 2025 06:49AM